Clinical improvement in psoriasis with specific targeting of interleukin-23.
Kopp T, Riedl E, Bangert C, Bowman EP, Greisenegger E, Horowitz A, Kittler H, Blumenschein WM, McClanahan TK, Marbury T, Zachariae C, Xu D, Hou XS, Mehta A, Zandvliet AS, Montgomery D, van Aarle F, Khalilieh S.
Kopp T, et al. Among authors: greisenegger e.
Nature. 2015 May 14;521(7551):222-6. doi: 10.1038/nature14175. Epub 2015 Mar 9.
Nature. 2015.
PMID: 25754330
Clinical Trial.